Date: August 8, 2018
Hosted by: brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA).
Presented by: Camille Gagnon, PharmD, Assistant Director, Canadian Deprescribing Network
Summary:
Medications allow Canadians to live longer and healthier lives. However, some medications may carry more risk than benefit, especially with aging. The burden of medication on cognitive health cannot be ignored and should be one of the first things assessed when cognitive impairment is diagnosed in a patient.
Learn about medications which may not necessarily be helping patients and how deprescribing (reducing or stopping medications that may not be beneficial or may be causing harm) can represent an interesting approach.
This integrated KTE webinar event is brought to you by brainXchange in partnership with the Alzheimer Society of Canada and the Canadian Consortium of Neurodegeneration in Aging (CCNA).
